 |
|
Contribution of Asymmetric Synapse Loss to Lateralizing Clinical Deficits in Frontotemporal Dementias
Anne M. Lipton, MD, PhD;
C. Munro Cullum, PhD;
Sivapong Satumtira, BS;
Estelle Sontag, PhD;
Linda S. Hynan, PhD;
Charles L. White, III, MD;
Eileen H. Bigio, MD
Arch Neurol. 2001;58:1233-1239.
Background Synapse loss has been found to be the major correlate of cognitive decline in Alzheimer disease (AD), and prefrontal synapse loss has been found in patients with frontotemporal dementia (FTD).
Objective To see if our hypothesis that within each FTD case, regional synapse loss would correlate with lateralizing neuropsychologic and neurobehavioral deficits would be correct.
Design We analyzed synaptophysin as a marker for synapse loss in snap-frozen brain samples, using an enzyme-linked immunosorbent assay technique. Quantitative results were obtained by comparing patient data with a standard curve made by analyzing serial dilutions of a recombinant synaptophysin protein fragment. A board-certified neuropsychologist and a board-certified neurologist, both unaware of the synaptophysin results, determined areas of primary neuropsychologic and neurobehavioral dysfunction. Relationships between areas of primary dysfunction and synapse loss were analyzed using the binomial test.
Patients Six cases of FTD, 28 cases of AD, and 16 nondemented control subjects.
Results Five of 6 FTD cases had regional synaptophysins correlating with lateralizing frontal or temporal deficits. Three of 6 correlated in 2 or more regions. Although our results were higher than that expected based on a pure-chance mechanism (50% vs 34%), statistical significance was not attained.
Conclusions We found a trend for an association between synapse loss and lateralizing neuropsychologic and neurobehavioral deficits in FTD. Studies in larger numbers of FTD cases are planned with the goal of attaining statistically significant conclusions.
From the Departments of Neurology (Drs Lipton and Cullum), Psychiatry (Drs Cullum and Hynan), Pathology (Mr Satumtira and Drs Sontag, White, and Bigio), and Academic Computing Services (Dr Hynan), University of Texas Southwestern Medical School at Dallas.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(8):1319-1321.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
CSF biomarkers in frontotemporal lobar degeneration with known pathology
Bian et al.
Neurology 2008;70:1827-1835.
ABSTRACT
| FULL TEXT
Distinct Antemortem Profiles in Patients With Pathologically Defined Frontotemporal Dementia
Grossman et al.
Arch Neurol 2007;64:1601-1609.
ABSTRACT
| FULL TEXT
TDP-43 Pathologic Lesions and Clinical Phenotype in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions
Grossman et al.
Arch Neurol 2007;64:1449-1454.
ABSTRACT
| FULL TEXT
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff et al.
Neurology 2007;68:1501-1508.
ABSTRACT
| FULL TEXT
Magnetic Resonance Imaging Signatures of Tissue Pathology in Frontotemporal Dementia
Whitwell et al.
Arch Neurol 2005;62:1402-1408.
ABSTRACT
| FULL TEXT
Different Patterns of Magnetic Resonance Imaging Atrophy for Frontotemporal Lobar Degeneration Syndromes
Short et al.
Arch Neurol 2005;62:1106-1110.
ABSTRACT
| FULL TEXT
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Coleman et al.
Neurology 2004;63:1155-1162.
ABSTRACT
| FULL TEXT
|
